Clinical Pharmacy, Pharmacokinetics and Drug Evaluation, Université de Lyon, Université Lyon 1, France.
Edouard Herriot Hospital, Laboratory of Medical Biology Multisites of University Hospital of Lyon, Pharmaco-Toxicology Unit, Hospices Civils de Lyon, Lyon, France.
Basic Clin Pharmacol Toxicol. 2019 May;124(5):600-606. doi: 10.1111/bcpt.13176. Epub 2018 Dec 28.
Inosine monophosphate dehydrogenase (IMPDH) is considered as the limiting enzyme of thiopurine metabolism for the formation of 6-thioguanine nucleotides (6-TGN). No data are available on the influence of RBC IMPDH activity on the metabolism of thiopurine drugs in individuals with IBD. The aims of this study were as follows: (a) to carry out a phenotypic study of RBC IMPDH activity in adults and children treated or not with azathioprine (AZA) for autoimmune diseases, and (b) to investigate the relationship between the activities of IMPDH, thiopurine metabolites, inosine triphosphatase (ITPA) and thiopurine methyltransferase (TPMT). IMPDH activity was determined in 97 adults and 67 children treated or not with AZA. 6-Thioguanine nucleotides (6-TGN), 6-methylmercaptopurine nucleotide (6-MeMPN) levels, and ITPA as well as TPMT activities were measured in RBCs by HPLC. Using the Gaussian mixture model, distribution of IMPDH activity was evaluated. Influence of age, sex and AZA treatment on IMPDH activity was also assessed. A bimodal distribution in IMPDH activity was found with 87% of patients exhibiting normal activity and 13% of patients with high activity. No influence of age, sex and AZA therapy was found. There is no relationship between TPMT, ITPA and IMPDH activities. A negative correlation between IMPDH activity and 6-MeMPN was shown in adults and children (rs = -0.335 P = 0.014 and rs = -0.383 P = 0.012, respectively). Our results suggest that AZA-treated patients exhibiting lower IMPDH activity could have higher Me-6MPN levels with higher risk of hepatotoxicity. We demonstrated that RBC matrix could be an interesting alternative to lymphocyte matrix to monitor thiopurine metabolites and enzyme activity.
肌苷单磷酸脱氢酶(IMPDH)被认为是硫嘌呤代谢的限速酶,可形成 6-硫鸟嘌呤核苷酸(6-TGN)。目前尚无关于红细胞 IMPDH 活性对 IBD 个体硫嘌呤药物代谢影响的数据。本研究的目的如下:(a)对接受或未接受硫唑嘌呤(AZA)治疗的成人和儿童的红细胞 IMPDH 活性进行表型研究,以及(b)研究 IMPDH、硫嘌呤代谢物、肌苷三磷酸酶(ITPA)和硫嘌呤甲基转移酶(TPMT)之间的关系。测定了 97 名成人和 67 名接受或未接受 AZA 治疗的儿童的 IMPDH 活性。通过 HPLC 测定 RBC 中的 6-硫鸟嘌呤核苷酸(6-TGN)、6-甲基巯基嘌呤核苷酸(6-MeMPN)水平和 ITPA 以及 TPMT 活性。使用高斯混合模型评估 IMPDH 活性的分布。还评估了年龄、性别和 AZA 治疗对 IMPDH 活性的影响。发现 IMPDH 活性呈双峰分布,87%的患者表现出正常活性,13%的患者表现出高活性。未发现年龄、性别和 AZA 治疗的影响。TPMT、ITPA 和 IMPDH 活性之间没有关系。在成人和儿童中,IMPDA 活性与 6-MeMPN 之间呈负相关(rs=-0.335,P=0.014 和 rs=-0.383,P=0.012)。我们的结果表明,表现出较低 IMPDH 活性的 AZA 治疗患者可能具有更高的 Me-6MPN 水平,肝毒性风险更高。我们证明,红细胞基质可能是监测硫嘌呤代谢物和酶活性的淋巴细胞基质的一个有趣替代物。